Vanda Pharmaceuticals





Ebit Cambiamento Data
Acadia Pharmaceuticals USD 35.76M 3.38M 2025-09
Agios Pharmaceuticals USD -116.87M 10.19M 2025-09
Akebia Therapeutics USD 13.51M 27.82M 2025-03
Alnylam Pharmaceuticals USD -29.96M 34.85M 2025-09
Anika Therapeutics USD -4.28M 3.58M 2025-03
Arrowhead Research USD 40.81M 17.01M 2025-12
AstraZeneca USD 2.97B 4.48B 2025-12
Bristol-Myers Squibb USD 3.47B 567M 2025-12
Eli Lilly USD 8.99B 1.57B 2025-12
Enanta Pharmaceuticals USD -23.54M 6.31M 2024-12
Esperion Therapeutics USD -16.03M 11.51M 2024-09
Halozyme Therapeutics USD 217.92M 15.48M 2025-09
Heron Therapeutics USD -4.46M 5.76M 2024-09
Insmed USD -261.35M 7.48M 2025-09
J&J USD 5.11B 2.3B 2025-12
Lexicon Pharmaceuticals USD -49.63M 5.39M 2023-09
Ligand Pharmaceuticals USD 158.89M 115.32M 2025-09
Merck USD 6.24B 1.32B 2025-12
Minerva Neurosciences USD -4.37M 1.71M 2024-09
Moderna USD -260M 557M 2025-09
Novartis USD 4.48B 343M 2025-09
Pfizer USD 4.65B 71M 2025-12
PTC Therapeutics USD 3.49M 38.35M 2025-09
Puma Biotechnology USD -2.2M 11.41M 2024-06
Sanofi EUR 1.7B 2.17B 2025-12
Takeda JPY 257.49B 568.56B 2025-12
Teva Pharmaceutical Industries USD 577M 491M 2025-12
Ultragenyx Pharmaceutical USD -170.89M 22.68M 2025-09
Vanda Pharmaceuticals USD -10.28M 721K 2024-12
Veracyte USD 23.11M 8.8M 2025-09


Vanda Pharmaceuticals - Valori correnti, dati storici, previsioni, statistiche, grafici e calendario economico - Feb 2026.